Gilead Sciences, Inc.
GILD
$138.92
$0.560.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -151.34% | 54.50% | 1,672.92% | 6,336.51% | 498.77% |
| Total Depreciation and Amortization | -0.36% | -0.72% | -0.25% | 0.14% | 0.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 476.15% | -20.08% | -68.12% | -81.73% | -65.07% |
| Change in Net Operating Assets | 18.00% | -149.38% | -348.64% | -50.10% | 53.09% |
| Cash from Operations | 37.33% | 4.24% | -7.47% | -3.54% | 32.14% |
| Capital Expenditure | -22.04% | -10.34% | -7.65% | 14.55% | 12.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,187.97% | 15.33% | 77.89% | 89.37% | 79.38% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 191.91% | -1,632.31% | -265.10% | -227.20% | -222.54% |
| Cash from Investing | -212.72% | -57.39% | -38.97% | 19.44% | 0.12% |
| Total Debt Issued | 17.93% | -- | -- | 346,300.00% | 74.95% |
| Total Debt Repaid | -48.15% | 25.19% | 9.24% | 8.97% | 53.91% |
| Issuance of Common Stock | -44.73% | -39.02% | -3.32% | 99.64% | 111.54% |
| Repurchase of Common Stock | 24.54% | -8.85% | -67.13% | -114.95% | -100.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.73% | -2.41% | -2.17% | -2.42% | -2.64% |
| Other Financing Activities | -97.56% | -30.59% | -56.58% | -58.80% | -40.30% |
| Cash from Financing | -13.01% | -55.66% | -125.60% | 37.84% | 40.68% |
| Foreign Exchange rate Adjustments | -137.04% | 2,166.67% | 330.00% | -38.46% | 3,950.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -182.88% | -109.29% | -162.16% | 442.75% | 180.87% |